Workflow
海利尔: 海利尔药业集团股份有限公司关于子公司制剂项目通过环保验收的公告

Project Investment Overview - The company approved the investment in a new formulation project by Qingdao Audis Biotechnology Co., Ltd. on October 28, 2019, with a planned construction period expected to last until 2021 and a budget of CNY 404.652 million [1] - The project includes multiple phases, such as a 7,000T water-based formulation project and various agricultural chemical formulation projects totaling 50,000T, with a revised budget and timeline extending to 2022 [1][2] Project Acceptance Status - Recently, Qingdao Audis Biotechnology Co., Ltd. received the completion environmental protection acceptance opinion for the 20,000T agricultural chemical formulation project, confirming that the project met environmental protection standards and was built in accordance with the environmental impact report [2][3] Impact on the Company - The project aligns with the company's strategic development plan, enhancing the supply capacity of formulation products and improving sustainable development and overall profitability [3] - The implementation of this project is expected to increase the production capacity of the company's main products, expand product varieties, and ensure advanced production levels, allowing for quicker market response and better customer service [3]